|
| 产地 | France |
| 保存条件 | |
| 品牌 | abinscience |
| 货号 | DT073018 |
| 用途 | 供科研使用 |
| 检测方法 | Colorimetric |
| 保质期 | 1 year |
| 适应物种 | Not Species Specific |
| 检测限 | |
| 数量 | 999 |
| 包装规格 | 96T |
| 标记物 | Unconjugated |
| 样本 | Plasma, Serum |
| 应用 | ELISA |
| 是否进口 |
| Product name | Faricimab ELISA Kit |
|---|---|
| Catalog No. | DT073018 |
| Applications | ELISA |
| Accession | P15692 & O15123 |
| Stability and Storage | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| Detection method | Colorimetric |
| Sample type | Plasma, Serum |
| Assay type | Quantitative |
| Sensitivity | 0.156 μg/ml |
| Background | Faricimab, an overall good safety and tolerability profile, is a bispecific antibody targeting Angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A). Faricimab prevents retinal vascular leakage, cell death and inflammation in retinal ischemia/reperfusion (I/R) injury and sCNV mouse models. Faricimab demonstrates statistically superior visual acuity gains versus Ranibizumab (HY-P9951). Faricimab can be used for retinal diseases, such as age-related macular degeneration (w-AMD), diabetic macular edema (DME) and macular edema following retinal vein occlusion (RVO). |
| Target | Faricimab |
| Range | 0.31-5 μg/mL |
| Recovery | 80-120% |
| Alternative Names | RG7716, RO6867461, CAS: 1607793-29-2 |
| Clone ID | \ |
| Shipping | 2-8 ℃ |
| Note | For Research Use Only. |
Abinscience, founded in 2023 and located in the innovation technology center in Strasbourg, France, is the core research reagent brand of ProteoGenix. Focusing on the development and production of life science research reagents, Abinscience takes "Empowering Bioscience Discovery" as its vision, and is committed to providing high-quality and innovative biological reagent products and technical solutions for global researchers.
返回顶部
